NeOnc Technologies Holdings Inc. (NASDAQ: NTHI) announced it has established the recommended phase 2 dose for its oral brain cancer ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE